ADA Scientific Sessions vs ENDO for Exhibitors
Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.
By Buzzbox Media · Last reviewed August 3, 2026
If you exhibit medical devices, ADA Scientific Sessions and ENDO are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. ADA Scientific Sessions draws 14,000 attendees with an estimated all-in 10×10 of $8,000-$15,000, read from the published exhibitor prospectus. ENDO draws 8,000 attendees with an estimated all-in 10×10 of $8,000-$15,000, read from the published exhibitor prospectus. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.
| 9.4 ENDO | ||
|---|---|---|
| Score | ||
| Buzzbox Score | 10.0 (Exceptional) | 9.4 (Exceptional) |
| Event Details | ||
| Dates | June 5-8, 2026 | June 13-16, 2026 (Expo: June 13-15) |
| Location | New Orleans, LA (Ernest N. Morial Convention Center) | Chicago, IL (McCormick Place West) |
| Scale | mega | large |
| Audience | ||
| Attendees | 14,000 | 8,000 |
| Exhibitors | n/a | n/a |
| Purchasing authority | ~45% | ~50% |
| Effective buyers | 6,300 | 4,000 |
| Costs | ||
| $/sqft | $42.5 | $41 |
| 10×10 space | $4,250 | $4,100 |
| All-in estimate | Est. $8,000-$15,000 | Est. $8,000-$15,000 |
| Cost per buyer | $1.83 | $2.88 |
Why exhibit at ADA Scientific Sessions
The world's largest and most prestigious diabetes research meeting, drawing 14,000+ attendees including the endocrinologists, diabetologists, and researchers who shape treatment protocols and influence formulary decisions globally. If you make glucose monitors, insulin delivery systems, CGMs, or diabetes pharmaceuticals, this is the single most important show of the year.
Why exhibit at ENDO
The premier meeting for the full breadth of endocrinology: thyroid, diabetes, reproductive, bone, adrenal, pituitary, and obesity. 260+ exhibitors and 7,000+ attendees make this the largest endocrine-specific meeting globally. Strong KOL presence for building clinical advocacy and physician education partnerships.
Why skip ADA Scientific Sessions
Heavily research-oriented with many academic attendees who do not make purchasing decisions. If your device is not diabetes-specific (e.g., general endocrine, thyroid, or metabolic), the audience focus is too narrow. 30% international attendees may not be relevant for US-only sales teams.
Why skip ENDO
If your product is diabetes-only, ADA Scientific Sessions is the more focused and higher-attendance venue. ENDO covers the full endocrine spectrum, so your booth will compete for attention across many subspecialties. Heavy academic/research orientation means many attendees are not direct purchasers.
ADA Scientific Sessions booth figures are estimates read from its published exhibitor prospectus ↗, not quotes. ENDO booth figures are estimates read from its published exhibitor prospectus ↗, not quotes. Confirm current pricing with each organizer before committing a budget.
Frequently Asked Questions
Is ADA Scientific Sessions or ENDO better for first-time exhibitors?
Both work, but ENDO is the lower-budget pilot. An all-in 10×10 at ENDO is estimated at $8,000 to $15,000, against $8,000 to $15,000 at ADA Scientific Sessions. ENDO also puts you on the smaller floor, with about 8,000 attendees against roughly 14,000 at ADA Scientific Sessions, so a modest first booth is less likely to get lost. Both ranges are Buzzbox Media estimates built from public prospectuses and exhibitor kits, covering space, drayage, electrical, carpet, and basic services but not travel, staffing, or the booth build. Confirm current pricing with each organizer before you commit a budget.
Does ADA Scientific Sessions or ENDO have more decision makers?
ADA Scientific Sessions does, on our estimate: roughly 6,300 effective buyers against about 4,000 at ENDO. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so ADA Scientific Sessions works out to about 14,000 attendees at roughly 45% authority, and ENDO to about 8,000 at roughly 50%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.
Want to add a third conference to this comparison?
Compare these conferences in our interactive tool →Other conferences you might consider
Buzzbox Media is a medtech marketing agency with over 15 years in medtech. See our conference marketing.